Patents by Inventor Leanne COOPER

Leanne COOPER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mammalian EphA4 polypeptide derivatives lacking one or more N-glycosylation sites and method of use thereof
    Patent number: 10617738
    Abstract: The present disclosure relates generally to the treatment of diseases and conditions exacerbated by signalling via the erythropoietin-producing-hepatoma receptor kinases EphA4 and to agents useful in such treatment.
    Type: Grant
    Filed: October 27, 2016
    Date of Patent: April 14, 2020
    Assignees: The University of Queensland, The Council of The Queensland Institute of Medical Research
    Inventors: Perry Bartlett, Andrew Boyd, Mike Gerometta, Leanne Cooper
  • METHOD OF TREATMENT AND AGENTS USEFUL FOR SAME
    Publication number: 20180339020
    Abstract: The present disclosure relates generally to the treatment of diseases and conditions exacerbated by signalling via the erythropoietin-producing-hepatoma receptor kinases EphA4 and to agents useful in such treatment.
    Type: Application
    Filed: October 27, 2016
    Publication date: November 29, 2018
    Inventors: Perry BARTLETT, Andrew BOYD, Mike GEROMETTA, Leanne COOPER